Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01721395 · ClinicalTrials.gov registry record · NA
Effect of Agave Syrup, Placebo, and No Treatment on Nocturnal Cough and Sleep Quality for Coughing Infants/Toddlers and Their Parents
A NA study of Cough, sponsored by Penn State University.
- Completed
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT01721395 is a NA study of Cough that has completed, run by Penn State University. The registered enrollment target is 120 participants, below the 212-participant average among 12 other Cough trials with a reported enrollment target (43% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01721395, a NA study of Cough, has completed, sponsored by Penn State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
Cough is a frequent symptom in children and infants and is one of the most common reasons parents visit a healthcare provider for their child. The US Food and Drug Administration has issued a warning that over-the-counter cough and cold medicines including antihistamines, decongestants, anti-tussives, and expectorants should not be administered to children younger than 2 years of age due not only to lack of proven efficacy, but also because of important safety concerns. Honey, another method of soothing cough cannot be used in children \<1 year due to concerns for infantile botulism. A preparation from agave syrup has been created to address the need for an infant cough syrup. Although no studies have formally evaluated the use of agave nectar for nocturnal cough associated with Upper Respiratory Infections, the demulcent effect and sweet taste of agave nectar may provide some relief from cough in children.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Agave Syrup
Study Locations (1)
Pennsylvania
- Penn State Hershey Medical Center - Hershey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2013-01 |
| Est. Completion | 2014-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01721395
The ClinicalTrials.gov registry entry for NCT01721395 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 212-participant average among 12 other Cough trials with a reported enrollment target (43% lower). The listed sponsor is Penn State University, which has 219 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cough appearing as the primary indexed condition, and to 1 intervention - of which Agave Syrup is the first listed.
NCT01721395 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT01721395 about?
NCT01721395 is a clinical study titled "Effect of Agave Syrup, Placebo, and No Treatment on Nocturnal Cough and Sleep Quality for Coughing Infants/Toddlers and Their Parents". Cough is a frequent symptom in children and infants and is one of the most common reasons parents visit a healthcare provider for their child. The US Food and Drug Administration has issued a warning that over-the-counter cough and cold medicines including antihistamines, decongestants, anti-tussive...
What is the current status of trial NCT01721395?
This trial is currently completed. It is a NA study. The enrollment target is 120 participants. The study started on 2013-01. Estimated completion is 2014-03.
What conditions does trial NCT01721395 study?
This clinical trial studies the following conditions: Cough.
What interventions are being tested in trial NCT01721395?
The interventions under investigation include: Agave Syrup (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01721395?
This trial is sponsored by Penn State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01721395 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cough
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Stimulation of the Larynx to Treat Unexplained Chronic Cough
RECRUITING · NA
-
Stimulation With Wire Leads to Restore Cough
COMPLETED · NA
-
A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough
RECRUITING · Phase 3
-
Office-Based Superior Laryngeal Nerve Block for Treatment of Neurogenic Cough
RECRUITING
-
The Mechanism Versus PPI Trial
RECRUITING · Phase 4
-
Work of Breathing Assessment in Triage Scale
ACTIVE NOT RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.